MedTrace Logo

Urine Sample Processing Study

NCT05483088 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 110

Last updated 2023-10-26

No results posted yet for this study

Summary

The objective of the study is to collect and process urine samples from Intensive Care Unit (ICU) subjects with moderate to severe (Stage 2 or 3) acute kidney injury (AKI) for use in assessing the effects of urine sample freezing and various storage conditions on NEPHROCLEAR™ CCL14 Test results. This study is observational and will have no impact on the medical management of the subject.

Conditions

Interventions

DIAGNOSTIC_TEST

Urine collection for NEPHROCLEAR CCL14 Test

Urine will be collected for analysis with the NEPHROCLEAR CCL14 Test

Sponsors & Collaborators

  • Astute Medical, Inc.

    lead INDUSTRY

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-12
Primary Completion
2023-07-31
Completion
2023-07-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05483088 on ClinicalTrials.gov